InvestorsHub Logo
Followers 49
Posts 8361
Boards Moderated 3
Alias Born 02/11/2008

Re: None

Saturday, 02/17/2018 12:50:15 PM

Saturday, February 17, 2018 12:50:15 PM

Post# of 21373
12,500,000 shares were diluted just so Redman and DPayne could take salarys in business that can't even admit to shareholders the name of there contracted manufacturer?

BioVectra Funding and agreement expired in 2016 and there has been no agreement brought forward as to who is producing Prolanta?

Why does BioVectra continue to refuse to answer the questions about Prolanta?

Manufacturing a Prolanta is expensive, money Oncolix does not have, If Oncolix had a manufacturer it would be in a filing because it would be through Toxing Finance, they don't have the funds in cash?

Where is the filing that shows the current manufacturer of Prolanta?

Moving on to Cohort 2 makes less sense then trying to prove Oncolix dosed a single patient with Prolanta in the last 2 years of clinical studies

No worries they can just continue to switch focus to different forms of cancer, this possible pyramid 3rd party promoted pump and dump scheme can go on for years

But as they continue to dilute and increase the amount of shares Redman gets his cut of that also

IMO

Everything I post, is In my own opinion, I don't care what you think about it, if you disagree, post it like I do. If you buy or sell stock based on what I say, your a lunatic and should not be trading. Have a great day!

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.